Merck’s profit plunges on charges

The pharmaceutical giant posts a dramatically lower third-quarter profit, due largely to steep charges taken in the 2010 period and hefty gains in the year-ago period.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.